$CLOV
stock+ Make pickLast price
$4.69
Today
▲ 9.21%
Open
$4.46
Day range
$4.40 – $4.71
Volume
2.9M
52-wk range
$1.58 – $5.59
where the room's targets sit vs price
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 20 | Soares KarenChief Legal Officer | Sell | −19.3K | $4.66 | $89.8K |
| Oct 19 | Reynoso Jamie L.CEO, Medicare Advantage | Sell | −4.1K | $4.41 | $17.9K |
| Oct 15 | Toy AndrewDirector · Chief Executive Officer | Sell | −62.2K | $4.68 | $291K |
| Oct 15 | Soares KarenChief Legal Officer | Sell | −14.7K | $4.68 | $68.7K |
| Oct 15 | THORNTON JOSEPH CLAYInterim CFO | Sell | −4.6K | $4.68 | $21.5K |
| Oct 15 | Wai ConradCEO, Counterpart Health | Sell | −23.6K | $4.68 | $111K |
| Oct 15 | Reynoso Jamie L.CEO, Medicare Advantage | Sell | −18.3K | $4.68 | $85.5K |
| Oct 7 | Reynoso Jamie L.CEO, Medicare Advantage | Sell | −2.0K | $4.63 | $9.3K |
| Oct 5 | Reynoso Jamie L.CEO, Medicare Advantage | Sell | −8.8K | $4.42 | $38.7K |
| Sep 30 | Miller Brian JamesDirector | Grant | +12.5K | $0.00 | $0 |
source: SEC EDGAR (Form 4 / 13D / 13G) · free
13D/13G = beneficial owners above 5%. A full institutional holdings table (13F) needs a quarterly bulk-ingest of every manager's filing — also free, planned next.